In summary, CKI could inhibit proliferation and induce apoptosis of BC cells, and the therapeutic mechanism of CKI against BC is likely to be closely related to its regulation of the VEGF signaling pathway by reversing the expression of PIK3CA, SRC, and NOS3. Here, NOS3 is linked to breast cancer.